An innovator in healthcare programs and solutions reviews the success of its platform more than a year after the passage of ICHRA. SANTA ANA, Calif.–(BUSINESS WIRE)–SureCo, a pioneer of employer programs and solutions that promote great health coverage while lowering costs and improving quality of care, is thrilled to mark one year of partnership with … [Read more…]
TWYMEEG® (Imeglimin) net sales in Japan for the quarter (July-September) grew four-fold over the prior quarter, in part due to the lifting of the prescription days limitation in September 2022, as recently reported by Sumitomo Pharma Phase 2 NASH Trial (DESTINY-1) for PXL065 met its primary efficacy endpoint for liver fat content reduction at 36 … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Systemic Lupus Erythematosus (SLE): Update Bulletin #2” newsletter has been added to ResearchAndMarkets.com’s offering. Gain new key opinion leader (KOL) insights on the latest events happening in Systemic Lupus Erythematosus (SLE) treatment landscape. Topics covered include expert opinions on the prospects of the Phase III BLISS-BELIEVE study which will assess co-administration of SC … [Read more…]
LOS ANGELES–(BUSINESS WIRE)–Sensate, a global wellness technology company that offers a patented relaxation device turning the tide on stress, announced today that the company has named Maryellen Gleason as the chair of the US-based board (effective November 1, 2022). Gleason succeeds Fiona Williams, who served as the company’s UK-based board chair. Sensate reincorporated in the … [Read more…]
Outbreak response to rapidly enhance community immunity GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced that their PharmaJet Tropis® Needle-free Injection System (NFIS) will be used in a door-to-door immunization campaign aimed at reducing the outbreak of circulating mutant poliovirus Type … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Nephroblastoma Treatment Market, by Type, by Drug Type, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. Nephroblastoma, also known as Wilms tumor, is the most prevalent kind of renal cancer among pediatrics. Although the exact cause of Wilms … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Prostate Cancer Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides the most up-to-date information on key pipeline products within the global Prostate Cancer market. It covers emerging therapies for Prostate Cancer in active clinical development stages including early and late stage clinical trials. The … [Read more…]
Bayer, together with the Bill & Melinda Gates Foundation, are jointly funding pre-clinical research in non-hormonal contraception This collaboration with the Bill & Melinda Gates Foundation will contribute to expanding access to contraceptive options that help address the unmet needs of women worldwide WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer announced today that it has received a grant from … [Read more…]
Twenty Additional Abstracts Accepted for Presentation UPPER NYACK, N.Y.–(BUSINESS WIRE)–#ACR22—CreakyJoints®, the digital, international patient community for people with all forms of arthritis and part of the Global Healthy Living Foundation, will describe key findings from a multidisciplinary steering committee that identified the critical research topics to decrease vaccine hesitancy and improve vaccine uptake in adults … [Read more…]
— Month 12 results from MIRROR randomized controlled trial to be featured on Nov. 13, 11:45 a.m. EST during plenary session at the American College of Rheumatology Convergence 2022 — — Imaging analyses visualize impact of KRYSTEXXA with methotrexate on reducing uric acid deposits in the joints, with a 95% mean reduction over 52 weeks, … [Read more…]
